2026. Neurotransmitters in the TME: Can Dopamine and Glutamate Be the Next Cancer Targets?. Journal of Biomolecules, Pathogenesis and Therapeutics. 2, 3 (Sep. 2026), 111–112. DOI:https://doi.org/10.68041/jbpt.v2i3/01.